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Abstract
Background: Cationic antimicrobial peptides (CAMPs) are well recognized to be promising as novel antimicrobial
and antitumor agents. To obtain novel skeletons of CAMPs, we propose a simple strategy using acid-amide
substitution (i.e. Glu®Gln, Asp®Asn) to confer net positive charge to natural non-antimicrobial sequences that
have structures distinct from known CAMPs. The potential of this strategy was verified by a trial study.
Methods: The pro-regions of nematode cecropin P1-P3 (P1P-P3P) were selected as parent sequences. P1P-P3P and
their acid-amide-substituted mutants (NP1P-NP3P) were chemically synthesized. Bactericidal and membrane-
disruptive activities of these peptides were evaluated. Conformational changes were estimated from far-ultraviolet
circular dichroism (CD) spectra.
Results: NP1P-NP3P acquired potent bactericidal activities via membrane-disruption although P1P-P3P were not
antimicrobial. Far-ultraviolet CD spectra of NP1P-NP3P were similar to those of their parent peptides P1P-P3P,
suggesting that NP1P-NP3P acquire microbicidal activity without remarkable conformational changes. NP1P-NP3P
killed bacteria in almost parallel fashion with their membrane-disruptive activities, suggesting that the mode of
action of those peptides was membrane-disruption. Interestingly, membrane-disruptive activity of NP1P-NP3P were
highly diversified against acidic liposomes, indicating that the acid-amide-substituted nematode cecropin pro-
region was expected to be a unique and promising skeleton for novel synthetic CAMPs with diversified
membrane-discriminative properties.
Conclusions: The acid-amide substitution successfully generated some novel CAMPs in our trial study. These novel
CAMPs were derived from natural non-antimicrobial sequences, and their sequences were completely distinct from
any categories of known CAMPs, suggesting that such mutated natural sequences could be a promising source of
novel skeletons of CAMPs.
Background
Cationic antimicrobial peptides (CAMPs) are well recog-
nized to be promising as novel antimicrobial and antitu-
mor agents. Natural CAMPs are structurally much
diverse (e.g., linear cationic a-helical CAMPs, those
enriched for specific amino acids, and those containing
disulphide bonds and stable b-sheets) [1]. Because each
category exhibits characteristic antimicrobial properties,
numerous researchers have tried to identify novel skele-
tons of natural CAMPs from various organisms over the
last two decades. Many categories of CAMPs were iden-
tified in the last century. However, most CAMPs which
were recently found were categorized in known groups,
suggesting that the search for novel skeletons may have
almost reached its limit. To find novel skeletons, non-
natural sequences have been also explored [2]. A major
trial is combinatorial chemistry or similar approach
such as construction of random peptide libraries and
high-throughput screening [3-9]. Although these
approaches produced some novel CAMPs, they are
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major categories of CAMPs are larger peptides that con-
tain specific higher order structures as mentioned above.
Introduction of non-natural peptide mimics is an alter-
native strategy [10-12]. This is an excellent strategy
which can overcome the limitations inherent to peptides
physical characteristics. A demerit of this strategy is that
those peptide mimics cannot be prepared as recombi-
nant products by ribosomal syntheses which can pro-
duce natural CAMPs.
In this study, we propose a simple strategy to obtain
novel larger skeletons of CAMPs which only contain
natural amino acids using acid-amide substitution (i.e.
Glu®Gln, Asp®Asn), as described below.
(1) CAMPs are basic molecules. The positive charge is
essential for antimicrobial activity, but most natural pro-
teins/peptides are not basic.
(2) Rather than being limited to a specific skeleton,
natural CAMPs are structurally diverse. Novel skeletons
of CAMPs can be screened from modified nonbasic
sequences that have structures distinct from known
CAMPs by acquisition of net positive charge.
(3) As such nonbasic parent sequences, natural non-
antimicrobial peptides or parts of proteins can be used.
(4) Substituting acidic residues with counterpart
amides (i.e. Glu®Gln, Asp®Asn) can neutralize nega-
tive charges and confer net positive charge if the parent
sequences contain substantial basic residues. Such sub-
stitution is “conservative,” which minimally affects the
unique structure of parent sequences in most cases.
Introduction of basic residues at random positions is
unfavorable because the sequences become uniform
with increasing substitution and the unique structures
of parent sequences are lost.
As a trial study, the pro-regions of nematode cecro-
pins were selected as parent sequences. Nematode
cecropins are natural antimicrobial peptides [13-15].
Four nematode cecropins (P1-P4) have been identified
in the pig roundworm, Ascaris suum [15]. A pro-region
(26-30 residues long) is conserved at the C terminus of
nematode cecropin precursors (Figure 1)[15]. It contains
4-6 acidic residues that might interact with mature pep-
tides to suppress their antimicrobial activity in the pre-
cursor form [16]. Basic residues including a unique
tribasic site, (H/R)RR, are also present at the N termi-
nus. These sequences are expected to be promising par-
ent sequences because the pro-regions have been
estimated to acquire strong net positive charges by acid-
amide substitution.
Methods
Peptides
Peptides used in this study were prepared at Biologica Co.,
(Nagoya, Japan). Briefly, the peptides were synthesized by
the Fmoc method, and purified by reverse phase HPLC.
The products were confirmed by time-of-flight mass spec-
trometry on a Voyager DE Mass Spectrometer, Applied
Biosystems (Foster city, CA, USA).
Microorganisms
E. coli JM109 was purchased from Takara (Otsu, Japan).
Saccharomyces cerevisiae MAFF113011 was obtained
from the National institute of Agrobiological Sciences,
Ibaraki, Japan. Other strains described below were trans-
ferred from the National Institute of Technology and
Evaluation, Kazusa, Japan: Staphylococcus aureus
IFO12732, Bacillus subtilis IFO3134, Micrococcus luteus
IFO12708, Pseudomonas aeruginosa IFO3899, Salmo-
nella typhimurium IFO13245 and Serratia marcescens
IFO3736.
Microbicidal assay
Microbicidal assay was performed as previously
described [17]. A low ionic strength condition was used
to detect bactericidal activity with higher sensitivity.
Briefly, each microbial strain in the mid-exponential
phase was suspended in 10 mM Tris/HCl, pH 7.5. The
microbial suspension was mixed with peptides. After 2 h
incubation, the suspension was diluted 1,000 times and
inoculated on to plates of IFO702 medium (1% polypep-
tone, 0.2% yeast extract, 0.1% MgSO4 7H2O, 2% agar).
The numbers of colonies were counted, and a plot of
peptide concentration vs colony number was created.
Hemolytic assay
Hemolytic assay was performed as previously described
[18]. Human erythrocytes were used. Hemolysis was
estimated as the leakage of haemoglobin. The erythro-
cytes were washed and resuspended in 10 mM Tris-HCl,
pH 7.5, containing 308 mM sucrose. The erythrocyte
suspension was diluted by 30%. The diluted suspension
was mixed with the equal volume of peptide solution
dissolved in the same buffer. After 0.5 h of incubation,
the test suspension was centrifuged to remove the intact
erythrocytes. The supernatant was diluted, and A540 was
measured. The hemolysis caused by pure water was
defined as 100% lysis. Amphotericin B was used as a
positive control.
Cytoplasmic membrane permeability assay
Cytoplasmic membrane permeabilization of S. aureus
was determined with a voltage-sensitive dye, diS-C3-(5)
[19]. Bacteria in the mid-exponential phase were sus-
pended in 10 mM Tris-HCl, pH 7.5 to an OD600 of
0.05. Changes in fluorescence were continuously moni-
tored using a RF-5300PC spectrofluorometer (Shimadzu,
Kyoto, Japan) at an excitation wavelength of 622 nm
and an emission wavelength of 670 nm. The bacterial
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peptides were added to the bacterial suspension after
the dye uptake was maximal. The maximal increase in
fluorescence due to disruption of the cytoplasmic mem-
brane was recorded.
Liposome disruption assay
Membrane-disrupting activity was estimated by liposome
disruption assay [19]. Bovine heart phosphatidylglycerol
(PG), egg cardiolipin (CL), and egg phosphatidylcholine
(PC) were purchased from Avanti Polar Lipids, Inc.,
Alabama, USA. A lipid film was prepared by rotary eva-
poration of lipid solution (1 mg lipid in 1 ml chloroform).
The lipid film was hydrated with 1 ml of 10 mM Tris-
HCl buffer (pH 7.5) containing 75 mM calcein. Lipid dis-
persions were sonicated and subjected to five freeze-thaw
cycles. Non-trapped calcein was removed by gel filtration
on a Sephacryl S-300 spin column (GE Healthcare Bio-
Science Corp., Piscataway, NJ, USA) equilibrated with
10 mM Tris-HCl (pH 7.5) containing 175 mM NaCl and
1 mM EDTA. These calcein-entrapped liposomes were
diluted at a ratio of 1:1000 in 10 mM Tris-HCl (pH 7.5)
containing 350 mM sucrose. Calcein release after mem-
brane disruption was evaluated by measuring fluores-
cence intensity at 515 nm with excitation at 492 nm on a
RF-5300PC spectrofluorometer at room temperature.
Circular dichroism (CD) spectroscopy
CD spectra were recorded on a J-720 spectropolarimeter
(JASCO, Tokyo, Japan) in the far-ultraviolet (UV) range
from 190 to 260 nm using a 0.1 cm thermostatted cell
at 25°C. Peptides were dissolved in 10 mM Tris-HCl
(pH 7.5) containing tri-fluoroethanol (TFE) at 0-100%.
For measurement under the presence of liposomes, pep-
tides were dissolved at 100 μg/ml containing 500 μg/ml
liposomes at 20°C.
Results and Discussion
Microbicidal activities
The pro-region of cecropin P1-P4 (P1P-P4P) and the
acid-amide-substituted mutants (acidic residues neutra-
lized P1P-P4P: NP1P-NP4P) were chemically synthe-
sized. The C-terminal-COOH was not modified. The
minimum bactericidal concentrations (MBCs) for these
peptides were estimated (Table 1). Parent peptides
(P1P-P4P) were not bactericidal at ≤300 μg/ml except
for weak activities of P3P. These results were expected
from the inhibitory effects of pro-regions to the activity
of mature peptides [16]. NP1P-NP3P displayed bacteri-
cidal activity against all tested Gram-positive bacteria (S.
aureus IFO12732, B. subtilis IFO3134, and M. luteus
IFO12708), some Gram-negative bacteria (P. aeruginosa
IFO3899, S. typhimurium IFO13245, and E. coli JM109),
and a yeast (S. cerevisiae MAFF113011). The Gram-
negative bacterium, S. marcescens IFO3736, was not
susceptible. NP3P was the most effective among these
peptides (e.g., MBC = 5 μg/ml against S. aureus
IFO12732). The MBCs of NP1P-NP3P were comparable
with those of mature nematode cecropins, which are
well-recognized, potent, natural CAMPs [15]. These
results suggest that the acid-amide substitution effec-
tively confers bactericidal activities to some tested par-
ent peptides. Only NP4P was not bactericidal at ≤300
μg/ml against all the tested microbes although enhancer
activity for membrane-disruptive antimicrobial peptides
was detected [19].
Figure 1 Sequence alignment. NP1P-NP4P are aligned with their parent sequences (P1P-P4P). Glu®Gln and Asp®Asn substitutions are
indicated as inverted characters. Basic residues are underlined. The calculated pI is represented on the right side of each sequence.
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Next, we examined if the acid-amide substitution would
cause conformational changes by using CD spectroscopy
(Figure 2). Far-UV CD spectra of NP1P-NP3P were
similar to those of their parent peptides P1P-P3P at var-
ious concentration of TFE. Interestingly, the profile of
TFE-dependent change of A222/A208 displayed a charac-
teristic meta-stable phase around 50% TFE both for
NP1P-NP3P and P1P-P3P series. These results suggest
that NP1P-NP3P acquire microbicidal activity by acid-
amide substitution without remarkable conformational
changes. Since the acid-amide substitution is expected
to be “structurally conservative”,o u rs t r a t e g yc o u l db e
applicable for design of novel CAMPs from natural non-
antimicrobial sequences which contain structures dis-
tinct from known CAMPs.
Mode of action
To elucidate the mode of action against living microbial
cells, the relationship between membrane-disruption
and bacterial killing activities of NP1P-NP3P was
assessed for Staphylococcus aureus IFO12732 (Figure 3).
NP1P-NP3P destroyed S. aureus membrane at <1/10
concentration of MBC although P1P-P3P were neither
membrane-disruptive nor bactericidal. Moreover, these
peptides killed bacteria in almost parallel fashion with
their membrane disruption activities. These results sug-
gest that the bactericidal activities of all the NP1P-NP3P
peptides against S. aureus are accomplished via mem-
brane-disruption. In contrast, only slight haemolytic
activities were detected for NP1P-NP3P, suggesting that
the membrane disruptive activities were selective against
microbial membranes (Table 2).
Membrane-disruptive activities against acidic-liposomes
Furthermore, membrane-disruptive activities against lipo-
somes were also estimated. A liposome dye-leakage assay
was used. P1P-P3P did not cause the dye-leakage at
≤300 μg/ml against the liposome membrane [molar ratio
of phosphatidylglycerol (PG):cardiolipin (CL) was 3:1],
which was negatively charged and mimicked the Gram-
positive cytoplasmic membrane, and the liposome mem-
brane consisting of only phosphatidylcholine (PC), which
was neutrally charged and mimicked eukaryotic mem-
branes. Far-UV CD spectra of P3P were almost identical
under the presence and absence of PG/CL liposomes,
suggesting that those peptides were not inserted into
hydrophobic regions of liposome membranes [20]. In
contrast, NP2P and NP3P damaged the PG/CL liposome
membrane at ≥0.3 μg/ml (Figure 4). The concentration
was equal or lower than MBCs against Gram-positive
bacteria, which were measured under identical ionic con-
ditions. NP3P (100 μg/ml) was precipitated under the
presence of higher concentration of PG/CL liposome
(500 μg/ml) although P3P was not affected under the
same condition, suggesting that NP3P acquired strong
interaction with PG/CL membrane by acid-amide substi-
tutions. Since CD spectra could not be measured, the
conformation of NP3P in the presence of PG/CL mem-
brane remains unclear. NP2P and NP3P did not affect
PC liposome membrane (data not shown), suggesting
that NP2P and NP3P selectively attack the negatively
charged membrane as usually found in bacteria. This
observation agreed with that those peptides did not
destroy erythrocyte membranes. It is noteworthy that
NP3P exhibited stronger bactericidal properties but
weaker membrane disruptive activities against PG/CL
membranes than those of NP2P, i.e., activities against
PG/CL were not parallel to those against S. aureus mem-
brane. In addition, NP1P did not exhibit membrane-
disruptive activity in PG/CL and PC membranes at
≤200 μg/ml. These results suggest that membrane-
disruptive activities of NP1P-NP3P are highly diversified
against PG/CL membranes although all of those peptides
are strongly harmful against S. aureus membrane. The
nematode cecropin pro-region is expected to be a unique
and promising skeleton for novel synthetic CAMPs with
diversified membrane-discriminative properties, i.e.,
CAMPs which exhibit distinct target-selectivity may be
generated using this skeleton.
Conclusions
The acid-amide substitution successfully generated some
novel CAMPs in our trial study. These novel CAMPs
Table 1 Minimum bactericidal concentrations (MBCs) of
NP1P-NP4P and their parent peptides
Microbes MBC, μg/ml
NP1P
(P1P)
NP2P
(P2P)
NP3P
(P3P)
NP4P
Gram-positive bacteria
Staphylococcus aureus IFO12732 10
(>300)
5
(>300)
5
(>300)
>300
(>300)
Bacillus subtilis IFO3134 30
(>300)
70
(>300)
20
(>300)
>300
(>300)
Micrococcus luteus IFO12708 30
(>300)
30
(>300)
10
(200)
>300
(>300)
Gram-negative bacteria
Pseudomonas aeruginosa
IFO3899
20
(>300)
70
(>300)
20
(70)
>300
(>300)
Salmonella typhimurium
IFO13245
30
(>300)
200
(>300)
20
(>300)
>300
(>300)
Serratia marcescens IFO3736 >300
(>300)
>300
(>300)
>300
(>300)
>300
(>300)
Escherichia coli JM109 10
(>300)
30
(>300)
7
(>300)
>300
(>300)
Yeasts
Sacchoromyces cerevisiae
MAFF113011
200
(>300)
100
(>300)
7
(>300)
>300
(>300)
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Page 4 of 7Figure 2 TFE-dependent change of far-UV CD spectra. NP1P-NP3P and P1P-P3P were examined. CD spectra in the presence of 0-100% TFE.
The profiles of TFE-dependent change of A222/A208 are also represented.
Figure 3 Dose-membrane disruption and -bactericidal effect curve of NP1P-NP3P against S. aureus IFO12732.T h e s ec u r v e sw e r e
simultaneously determined. The asterisks indicate that viable cells were not detected. Disruption of the cytoplasmic membrane was estimated
by the increase in fluorescence intensity of diS-C3-(5). Changes in fluorescence were normalized by the value at the plateau of the dose-
response curves.
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and their sequences were completely distinct from any
categories of known CAMPs. In addition, remarkable
conformational changes were not detected between
parent and substituted peptides although further study
was necessary to estimate the conformation in the pre-
sence of membranes. This observation suggested that
acid-amide substitution was a promising method to
generate novel skeletons of CAMPs from natural non-
antimicrobial sequences that have structures distinct
from known CAMPs. This platform should not be lim-
ited to acid-amide substitution or natural parent
sequences. Combination with limited introduction of
basic residues and/or use of chimera sequences with
some natural sequences might expand the flexibility of
this platform.
Acid-amide substitution occurs at a high frequency in
the mutations of natural proteins [21]. Such substituted
residues could be accommodated in the structure and
function of the parent proteins. The accumulation of
acid-amide substitutions and gain of net positive charge
could occasionally confer antimicrobial activities. This is
a presumable scenario for the birth of natural CAMPs.
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